The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain

  1. Azanza, J.R.
  2. Grau, S.
  3. Vázquez, L.
  4. Rebollo, P.
  5. Peral, C.
  6. López-Ibáñez de Aldecoa, A.
  7. López-Gómez, V.
Aldizkaria:
Mycoses

ISSN: 1439-0507 0933-7407

Argitalpen urtea: 2021

Alea: 64

Zenbakia: 1

Orrialdeak: 66-77

Mota: Artikulua

DOI: 10.1111/MYC.13189 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak